Connections Regeneron Pharmaceuticals, Inc.

REGN

US75886F1075

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-09 pm EDT			5-day change	1st Jan Change
767.85 ^USD	-0.99%		+0.79%	-0.52%

Apr. 08	Bernstein Adjusts Regeneron Pharmaceuticals Price Target to $921 From $925, Maintains Outperform Rating	MT
Apr. 08	Regeneron Expects $0.81 per Share Net Income Impact From $102 Million R&D Charges for Q1	MT

27

Listed companies

12

Private companies

116

Insiders

Relation chart of related listed companies: Regeneron Pharmaceuticals, Inc.

Active Relations

Past Relations

Related listed companies: Regeneron Pharmaceuticals, Inc.

NEUROCRINE BIOSCIENCES, INC.

Christine Poon

IONIS PHARMACEUTICALS, INC.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Craig Thompson

PRUDENTIAL FINANCIAL, INC.

Christine Poon

CYTOKINETICS, INCORPORATED

Robert Landry

OCULAR THERAPEUTIX, INC.

COHERUS ONCOLOGY, INC.

Denny Lanfear

IMMUNEERING CORPORATION

Harold Brakewood

CRISPR THERAPEUTICS AG

Christian Rommel

4D MOLECULAR THERAPEUTICS, INC.

Julie Clark

DENALI THERAPEUTICS INC.

David Schenkein

Marc Tessier-Lavigne

REPLIMUNE GROUP, INC.

Arleen Goldenberg

ANNEXIN PHARMACEUTICALS AB

Alain Thibault

TENAYA THERAPEUTICS, INC.

Catherine Stehman-Breen

DYNE THERAPEUTICS, INC.

Catherine Stehman-Breen

SIONNA THERAPEUTICS, INC.

Marcella Ruddy

BAUSCH + LOMB CORPORATION

Manisha A. Narasimhan

ARRIVENT BIOPHARMA, INC.

Active Relations

Past Relations

Relationship chart for related private companies: Regeneron Pharmaceuticals, Inc.

Active Relations

Past Relations

Related private companies: Regeneron Pharmaceuticals, Inc.

Biotechnology Innovation Organization

Miscellaneous Commercial Services

N. Coles

David Schenkein

The Royal Society

Investment Trusts/Mutual Funds

Howard Hughes Medical Institute, Inc.

Investment Trusts/Mutual Funds

Joseph Goldstein

Craig Thompson

Huda Zoghbi

National Academy of Sciences

Miscellaneous Commercial Services

American Academy of Arts & Sciences

Miscellaneous Commercial Services

National Academy of Medicine (United States)

Miscellaneous Commercial Services

American Philosophical Society

Miscellaneous Commercial Services

The Column Group LLC

Investment Managers

Michael Brown

Joseph Goldstein

Huda Zoghbi

The University of Texas Southwestern Medical Center

Other Consumer Services

Michael Brown

Joseph Goldstein

Checkmate Pharmaceuticals, Inc.

Biotechnology

Robert Landry

Nouhad Husseini

Decibel Therapeutics, Inc.

Pharmaceuticals: Major

Joseph LaRosa

Robert Landry

Nouhad Husseini

GanD, Inc.

Medical/Nursing Services

George Sing

Robert Landry

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major	14
Biotechnology	11
Miscellaneous Commercial Services	6
Investment Trusts/Mutual Funds	2
Medical/Nursing Services	1
Other Consumer Services	1
Investment Managers	1
Pharmaceuticals: Other	1
Medical Specialties	1
Life/Health Insurance	1

Countries of related companies

United States	33
Germany	2
United Kingdom	1
Canada	1
Sweden	1
Switzerland	1

Regeneron Pharmaceuticals, Inc. specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Net sales break down by type of revenue as follows: - revenues from collaboration agreements (51.1%): collaboration with Sanofi (80.3% of revenues), Bayer (19.4%) and other (0.3%); - revenues from product sales (30%); - revenues from sales of technology licenses and subcontracted research services (4.9%). At the end of 2025, the group had a portfolio of approximately 45 products in clinical development.

Employees

15,410

Sector

Pharmaceuticals

Calendar

Apr. 29 - Earnings release - Q1 2026

More about the company